SlateStone Wealth’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$526K Buy
5,515
+40
+0.7% +$3.84K 0.04% 219
2026
Q1
$567K Buy
5,475
+395
+8% +$44.8K 0.05% 211
2025
Q4
$512K Sell
5,080
-110
-2% -$11.9K 0.04% 213
2025
Q3
$640K Hold
5,190
0.06% 195
2025
Q2
$623K Hold
5,190
0.06% 193
2025
Q1
$764K Hold
5,190
0.08% 168
2024
Q4
$843K Buy
5,190
+175
+3% +$28.6K 0.08% 167
2024
Q3
$817K Buy
5,015
+25
+0.5% +$3.71K 0.07% 173
2024
Q2
$681K Hold
4,990
0.07% 180
2024
Q1
$764K Buy
+4,990
New +$745K 0.08% 172
2019
Q4
Sell
-4,518
Closed -$686K 214
2019
Q3
$686K Hold
4,518
0.2% 88
2019
Q2
$692K Sell
4,518
-525
-10% -$80.2K 0.19% 94
2019
Q1
$809K Buy
5,043
+605
+14% +$93.9K 0.25% 81
2018
Q4
$684K Buy
+4,438
New +$691K 0.31% 61

Other funds holding CLX

SlateStone Wealth's CLX Position: Q2 2026 in Review

SlateStone Wealth increased its Clorox (CLX) stake by 0.73% in Q2 2026, buying an estimated $3.84K and bringing the position to 5,515 shares worth $526K. The position accounts for 0.04% of the portfolio, ranked #219.

SlateStone Wealth first reported a position in CLX in Q4 2018 and has held it in 14 quarters since. The position peaked at $843K in Q4 2024. 218 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • SlateStone Wealth held 5,515 shares of Clorox worth $526K as of Q2 2026.
  • SlateStone Wealth bought 40 Clorox shares in Q2 2026, an estimated $3.84K.
  • Clorox made up 0.04% of SlateStone Wealth's portfolio in Q2 2026, its #219 holding.
  • SlateStone Wealth first reported a position in Clorox in Q4 2018 and has held it in 14 quarters since.
  • SlateStone Wealth's Clorox position peaked at $843K in Q4 2024.
  • 218 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on SlateStone Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.